Commentary & Opinion
Houston Chronicle: Our Deadly, Costly Choices
March 29, 2011
In an editorial, the Houston Chronicle writes, "Last week, Texas state budget writers declined to include $19.2 million in additional funding for the Texas HIV Medication Program, which pays for essential medications for about 14,000 low-income Texans and is currently funded at $109 million. ... the program will have to be drastically restructured to accommodate the expected 14 percent growth in participants over the next two years ... the case for allocating priority funding for patients with HIV and AIDS is particularly strong when one considers both the human and economic costs of failing to do so" (3/28).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)